From life-changing medical advancements to colorful auroras, this year has been packed with incredible science. It was hard ...

Monlunabant is a small molecule commercialized by Novo Nordisk, with a leading Phase II program in Diabetic Nephropathy.

Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns ...

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...